Answers are grounded in this paper and cite their sources.
The available literature suggests that CHC treatment is effective for relief of endometriosis-related dysmenorrhea, pelvic pain, and dyspareunia; however, the supportive data are of low quality. Furthermore, insufficient data exist to reach conclusions about the overall superiority of any given CHC therapy, and the relative benefit in comparison to other approaches. Additional high-quality studies are needed to clarify the role of CHC agents and other treatments in women with endometriosis-related pain.
No takes yet. Share an insight, caveat, or question.
Jensen et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: